The association of erythropoietin-stimulating agents and increased risk for AV-fistula dysfunction in hemodialysis patients. A retrospective analysis
Patients in maintenance hemodialysis (HD) need a patent vascular access for optimal treatment. The recommended first choice is a native arteriovenous fistula (AVF). Complications of AVF are frequent and includ...
Source: BMC Nephrology - Category: Urology & Nephrology Authors: Anna W ärme, Henrik Hadimeri, Salmir Nasic and Bernd Stegmayr Tags: Research article Source Type: research